Health and Fitness FDA Approves Imbruvica for Rare Blood Cancer by Gary Kopycinski on November 14, 2013 Gary Kopycinski Author More in Health and Fitness: On Hantavirus, Park Forest Officials Urge Caution May 18, 2026 Rep. Kelly Condemns FDA Approval of Flavored E-Cigarettes May 6, 2026 Park Forest Aligns With Illinois Guidance on Childhood Vaccines Amid Federal Changes January 11, 2026 Second drug with breakthrough therapy designation to receive FDA approval